Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018
Influence of statin therapy on exacerbation frequency in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 7s Year: 2005
Impact of roflumilast treatment on the rate and duration of exacerbations and overall steroid load in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011
Evaluation of contribution of high frequency chest wall oscillation treatment to medical treatment in patients with acute exacerbations of COPD Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Influence of age on evolution of asthma control level and treatment compliance under ICS/LABA therapy Source: Eur Respir J 2005; 26: Suppl. 49, 382s Year: 2005
Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 15s Year: 2004
May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001
Reslizumab reduces severe exacerbations associated with emergency department visit or hospitalization and improves measures of lung function in patients on maintenance oral corticosteroids (OCS) at baseline Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD Source: Eur Respir J 2016; 47: 651-654 Year: 2016
Inhaled antibiotic treatment reduces the frequency of infective exacerbations in bronchiectasis: a single center, real life study Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
The clinical value of initial microbiological studies in exacerbations of COPD is questionable and not affected by antibiotics prior to hospitalization Source: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Delayed adjustment in maintenance therapy in patients with worsening asthma symptoms Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006
Noneosinophilic asthma: persistence over time and effect of treatment Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006
Is controlled oxygen therapy in COPD patients presenting in acute respiratory failure sub-optimal prior to commencement of NIV? Source: Annual Congress 2012 - COPD exacerbation Year: 2012
Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas induced COPD Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Impact of morning symptoms experienced by COPD patients on exacerbation risk, rescue inhaler usage and normal daily activities Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020